The Digital Therapeutics Alliance Welcomes Introduction of Bipartisan Legislation to Provide Guidance to U.S. States on Public Coverage Options for Prescription Digital Therapeutics
This bipartisan legislation is championed by Senators
This legislation provides much-needed clarity for states intending to provide access to digital therapeutics and comes at a critical moment for patients, when many are unable to access other forms of necessary therapies. Using this guidance to leverage existing pathways to expand access to DTx products for Medicaid-covered populations will enable those with chronic and mental health conditions to access expanded care options that can make a tremendous difference in their quality of life and healthcare outcomes.
In addition to providing critical guidance to enable more standardized coverage decisions across the country, the Medicaid and CHIP Access to Prescription Digital Therapeutics Act (S.5238) would also allow the Secretary of
“Digital therapeutics hold particular value for Medicaid populations with convenient, accessible, and personalized treatment options to address many unmet medical needs,” says
Hannah Fairman Digital Therapeutics Alliance 703-828-7359 [email protected]
Source:
National Online Life Insurance Program for PK-12 Public School Employees Offered by Wisconsin's WEA Member Benefits
Unregistered NDIS providers are in the firing line – but lots of participants have good reasons for using them
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News